Arizona State Retirement System Has $462,000 Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Arizona State Retirement System increased its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 2.4% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,574 shares of the company’s stock after purchasing an additional 617 shares during the quarter. Arizona State Retirement System’s holdings in Privia Health Group were worth $462,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in PRVA. Nisa Investment Advisors LLC increased its position in Privia Health Group by 107.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock valued at $31,000 after acquiring an additional 930 shares in the last quarter. Signaturefd LLC lifted its stake in Privia Health Group by 46.3% in the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after purchasing an additional 626 shares during the last quarter. Park Place Capital Corp lifted its position in Privia Health Group by 115.4% during the first quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock worth $49,000 after acquiring an additional 1,335 shares during the last quarter. Covestor Ltd lifted its position in Privia Health Group by 25.5% during the first quarter. Covestor Ltd now owns 5,292 shares of the company’s stock worth $104,000 after acquiring an additional 1,076 shares during the last quarter. Finally, SG Americas Securities LLC bought a new position in shares of Privia Health Group during the first quarter worth approximately $131,000. Institutional investors and hedge funds own 94.48% of the company’s stock.

Insider Transactions at Privia Health Group

In other news, CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total value of $2,500,127.00. Following the completion of the sale, the chief executive officer now directly owns 247,771 shares of the company’s stock, valued at approximately $4,583,763.50. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 14.20% of the company’s stock.

Privia Health Group Stock Down 1.4 %

Shares of PRVA opened at $18.69 on Tuesday. The stock has a market capitalization of $2.23 billion, a P/E ratio of 124.60, a PEG ratio of 4.40 and a beta of 0.77. The firm has a fifty day simple moving average of $19.43 and a two-hundred day simple moving average of $18.73. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $24.35.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.02). The firm had revenue of $422.30 million for the quarter, compared to analysts’ expectations of $411.50 million. Privia Health Group had a net margin of 0.88% and a return on equity of 2.42%. The company’s quarterly revenue was up 2.2% on a year-over-year basis. During the same period in the previous year, the company earned $0.06 EPS. Sell-side analysts expect that Privia Health Group, Inc. will post 0.16 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently issued reports on PRVA shares. Baird R W raised shares of Privia Health Group to a “strong-buy” rating in a research note on Thursday, May 30th. Evercore ISI cut their price target on shares of Privia Health Group from $23.00 to $20.00 and set an “outperform” rating on the stock in a report on Tuesday, July 9th. Barclays dropped their target price on shares of Privia Health Group from $22.00 to $19.00 and set an “equal weight” rating on the stock in a report on Monday, May 20th. Robert W. Baird boosted their target price on shares of Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, August 26th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $28.00 price target on shares of Privia Health Group in a research note on Wednesday, August 14th. Two analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Privia Health Group presently has an average rating of “Moderate Buy” and an average price target of $24.86.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.